Evidence Table for Clinical Management Recommendations for Mammograms by Breast Imaging Reporting and Data System (BI-RADS) Category
| BI-RADS Category | Assessment | Clinical Management Recommendation(s) | Strength of Recommendation | References | Comments on References |
|---|---|---|---|---|---|
| 0 | Assessment incomplete | Need to review prior studies and/or complete additional imaging | A | 3 | All or none study; consensus guidelines |
| 1 | Negative | Continue routine screening | A | 3, 8 | Consensus guidelines; validated clinical decision tool |
| 2 | Benign finding | Continue routine screening | A | 3, 8 | Consensus guidelines; validated clinical decision tool |
| 3 | Probably benign finding | Short-term follow-up mammogram at 6 months, then every 6 to 12 months for 1 to 2 years | B | 3, 6, 8, 10–15 | Consensus guidelines; cohort studies; large case series; validated decision tool; less patient stress; lowered costs with surveillance |
| 4 | Suspicious abnormality | Perform biopsy, preferably needle biopsy | A | 3, 8–10 | All or none study; validated clinical decision tool |
| 5 | Highly suspicious of malignancy; appropriate action should be taken. | Biopsy and treatment, as necessary. | A | 3, 8–10 | All or none study; validated clinical decision tool |
| 6 | Known biopsy-proven malignancy, treatment pending | Assure that treatment is completed |